Literature DB >> 12506200

Amyloid beta -protein (Abeta) assembly: Abeta 40 and Abeta 42 oligomerize through distinct pathways.

Gal Bitan1, Marina D Kirkitadze, Aleksey Lomakin, Sabrina S Vollers, George B Benedek, David B Teplow.   

Abstract

Amyloid beta-protein (Abeta) is linked to neuronal injury and death in Alzheimer's disease (AD). Of particular relevance for elucidating the role of Abeta in AD is new evidence that oligomeric forms of Abeta are potent neurotoxins that play a major role in neurodegeneration and the strong association of the 42-residue form of Abeta, Abeta42, with the disease. Detailed knowledge of the structure and assembly dynamics of Abeta thus is important for the development of properly targeted AD therapeutics. Recently, we have shown that Abeta oligomers can be cross-linked efficiently, and their relative abundances quantified, by using the technique of photo-induced cross-linking of unmodified proteins (PICUP). Here, PICUP, size-exclusion chromatography, dynamic light scattering, circular dichroism spectroscopy, and electron microscopy have been combined to elucidate fundamental features of the early assembly of Abeta40 and Abeta42. Carefully prepared aggregate-free Abeta40 existed as monomers, dimers, trimers, and tetramers, in rapid equilibrium. In contrast, Abeta42 preferentially formed pentamerhexamer units (paranuclei) that assembled further to form beaded superstructures similar to early protofibrils. Addition of Ile-41 to Abeta40 was sufficient to induce formation of paranuclei, but the presence of Ala-42 was required for their further association. These data demonstrate that Abeta42 assembly involves formation of several distinct transient structures that gradually rearrange into protofibrils. The strong etiologic association of Abeta42 with AD may thus be a result of assemblies formed at the earliest stages of peptide oligomerization.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12506200      PMCID: PMC140968          DOI: 10.1073/pnas.222681699

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

Review 1.  Targeting small Abeta oligomers: the solution to an Alzheimer's disease conundrum?

Authors:  W L Klein; G A Krafft; C E Finch
Journal:  Trends Neurosci       Date:  2001-04       Impact factor: 13.837

2.  In-situ atomic force microscopy study of beta-amyloid fibrillization.

Authors:  H K Blackley; G H Sanders; M C Davies; C J Roberts; S J Tendler; M J Wilkinson
Journal:  J Mol Biol       Date:  2000-05-19       Impact factor: 5.469

3.  Amyloid beta-protein oligomerization: prenucleation interactions revealed by photo-induced cross-linking of unmodified proteins.

Authors:  G Bitan; A Lomakin; D B Teplow
Journal:  J Biol Chem       Date:  2001-07-05       Impact factor: 5.157

4.  The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Abeta protofibril formation.

Authors:  C Nilsberth; A Westlind-Danielsson; C B Eckman; M M Condron; K Axelman; C Forsell; C Stenh; J Luthman; D B Teplow; S G Younkin; J Näslund; L Lannfelt
Journal:  Nat Neurosci       Date:  2001-09       Impact factor: 24.884

5.  Identification and characterization of key kinetic intermediates in amyloid beta-protein fibrillogenesis.

Authors:  M D Kirkitadze; M M Condron; D B Teplow
Journal:  J Mol Biol       Date:  2001-10-05       Impact factor: 5.469

6.  Nucleated conformational conversion and the replication of conformational information by a prion determinant.

Authors:  T R Serio; A G Cashikar; A S Kowal; G J Sawicki; J J Moslehi; L Serpell; M F Arnsdorf; S L Lindquist
Journal:  Science       Date:  2000-08-25       Impact factor: 47.728

Review 7.  Alzheimer's amyloid fibrils: structure and assembly.

Authors:  L C Serpell
Journal:  Biochim Biophys Acta       Date:  2000-07-26

Review 8.  Biochemical detection of Abeta isoforms: implications for pathogenesis, diagnosis, and treatment of Alzheimer's disease.

Authors:  T E Golde; C B Eckman; S G Younkin
Journal:  Biochim Biophys Acta       Date:  2000-07-26

9.  The assembly of amyloidogenic yeast sup35 as assessed by scanning (atomic) force microscopy: an analogy to linear colloidal aggregation?

Authors:  S Xu; B Bevis; M F Arnsdorf
Journal:  Biophys J       Date:  2001-07       Impact factor: 4.033

10.  Protofibrillar intermediates of amyloid beta-protein induce acute electrophysiological changes and progressive neurotoxicity in cortical neurons.

Authors:  D M Hartley; D M Walsh; C P Ye; T Diehl; S Vasquez; P M Vassilev; D B Teplow; D J Selkoe
Journal:  J Neurosci       Date:  1999-10-15       Impact factor: 6.167

View more
  400 in total

1.  Effects of the English (H6R) and Tottori (D7N) familial Alzheimer disease mutations on amyloid beta-protein assembly and toxicity.

Authors:  Kenjiro Ono; Margaret M Condron; David B Teplow
Journal:  J Biol Chem       Date:  2010-05-07       Impact factor: 5.157

2.  An improved method for generating consistent soluble amyloid-beta oligomer preparations for in vitro neurotoxicity studies.

Authors:  Deborah A Ryan; Wade C Narrow; Howard J Federoff; William J Bowers
Journal:  J Neurosci Methods       Date:  2010-05-07       Impact factor: 2.390

3.  Preparation and characterization of toxic Abeta aggregates for structural and functional studies in Alzheimer's disease research.

Authors:  Asad Jan; Dean M Hartley; Hilal A Lashuel
Journal:  Nat Protoc       Date:  2010-06-03       Impact factor: 13.491

4.  Molecular dynamics simulation of amyloid beta dimer formation.

Authors:  B Urbanc; L Cruz; F Ding; D Sammond; S Khare; S V Buldyrev; H E Stanley; N V Dokholyan
Journal:  Biophys J       Date:  2004-10       Impact factor: 4.033

5.  Aβ(39-42) modulates Aβ oligomerization but not fibril formation.

Authors:  Megan Murray Gessel; Chun Wu; Huiyuan Li; Gal Bitan; Joan-Emma Shea; Michael T Bowers
Journal:  Biochemistry       Date:  2011-12-23       Impact factor: 3.162

6.  Solid-support electron paramagnetic resonance (EPR) studies of Aβ40 monomers reveal a structured state with three ordered segments.

Authors:  Lei Gu; Sam Ngo; Zhefeng Guo
Journal:  J Biol Chem       Date:  2012-01-25       Impact factor: 5.157

7.  Probing the efficacy of peptide-based inhibitors against acid- and zinc-promoted oligomerization of amyloid-β peptide via single-oligomer spectroscopy.

Authors:  Lyndsey R Powell; Kyle D Dukes; Robin K Lammi
Journal:  Biophys Chem       Date:  2011-09-08       Impact factor: 2.352

8.  Distinguishing amyloid fibril structures in Alzheimer's disease (AD) by two-dimensional ultraviolet (2DUV) spectroscopy.

Authors:  A R Lam; J Jiang; S Mukamel
Journal:  Biochemistry       Date:  2011-10-20       Impact factor: 3.162

9.  Increased BACE1 mRNA and noncoding BACE1-antisense transcript in sporadic inclusion-body myositis muscle fibers--possibly caused by endoplasmic reticulum stress.

Authors:  Anna Nogalska; W King Engel; Valerie Askanas
Journal:  Neurosci Lett       Date:  2010-03-15       Impact factor: 3.046

10.  Identification of brain-targeted bioactive dietary quercetin-3-O-glucuronide as a novel intervention for Alzheimer's disease.

Authors:  Lap Ho; Mario G Ferruzzi; Elsa M Janle; Jun Wang; Bing Gong; Tzu-Ying Chen; Jessica Lobo; Bruce Cooper; Qing Li Wu; Stephen T Talcott; Susan S Percival; James E Simon; Giulio Maria Pasinetti
Journal:  FASEB J       Date:  2012-10-24       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.